CIK 0001735438
- Non-accelerated filer
- Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981448305
- Phone
- +1 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- 4 Open-market sale Chief Development Officer sold 12,000 shares at $17.95 ($215,400)
- 4 Open-market sale Chief Development Officer sold 9,390 shares at $15.06 ($141,413)
- 4 Open-market sale Chief Development Officer sold 2,610 shares at $15.04 ($39,254)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 30,000 shares at an average $15.02 ($450,740)
- 4 Open-market sale Chief Development Officer sold 6,082 shares at an average $15.01 ($91,301)
- 4/A Open-market sale Chief Development Officer sold 5,918 shares at an average $15.10 ($89,334)
- 4 Open-market sale Chief Development Officer sold 5,177 shares at an average $15.11 ($78,211)
- 4 Exercise or conversion Director acquired 12,882 shares (option exercise)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $15.59 ($467,550)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 13 · 260 filings